awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36232280-4E9F7127-B5E3-4843-A450-3BC67D195349
Q36232280-4E9F7127-B5E3-4843-A450-3BC67D195349
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36232280-4E9F7127-B5E3-4843-A450-3BC67D195349
Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide
P2860
Q36232280-4E9F7127-B5E3-4843-A450-3BC67D195349
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36232280-4E9F7127-B5E3-4843-A450-3BC67D195349
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
702188d218647b7eef82fa8e2f2f823e95b26d10
P2860
Increasing CHADS2 scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleeding